Answers are grounded in this paper and cite their sources.
The microbial involvement in gastrointestinal tract (GIT) diseases has been extensively studied during the last two decades. However, their implication in GIT diseases is often oversimplified with indications that microbial dysbiosis is a foremost reason. In this article, we examine a host-first model in which genetic susceptibility, immune dysregulation, epithelial-barrier dysfunction, and lifestyle can initiate aberration in the intestinal microenvironment that subsequently reshapes the gut microbiome. This relationship is bidirectional: microbiota-derived metabolites antigens expansion may also impair barrier function and dysregulate mucosal immunity, thereby initiating/amplifying inflammation in susceptible hosts. In support of the argument, key defects in human genes (e.g. FUT2, FOXP3, IL10, HNFA, IL23R, NOD2, MUC2, and XBP1) and their impact on the host’s intestinal barrier, and mucosal innate immunity have been discussed. Beyond monogenic genetic defects, the review highlights the involvement of genetic stimuli, where mutations remain asymptomatic until activated by infection or environmental factors. We propose a triangular, bidirectional model in which host susceptibility and environment exposures alter immune and epithelial homeostasis, while the microbiome can both respond to and reinforce these disturbances. The relative contribution and temporal order of these components are likely to differ among diseases and individuals.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: